New Delhi: Medication Controller General India (DCGI) on Friday gave permission to Bharat Biotech to trial in an intranasal amplifier in India.
The trial will be carried out in nine different sites.
Hyderabad-based manufacturers have proposed a booster dose for those who have not been inoculated with covishield and covaxin vaccines.
According to a source, Bharat Biotech aims to conduct clinical trials at 5,000 healthy subjects: half or 2,500 individuals who have received the covishield and 2,500 others who have given Covaxin.
There will be a gap about six months between the second and intranasal booster dose.
The source said that the Nasal Booster vaccine was likely to be launched in India in March after the clinical trial.
In his speech to the country on December 25, Prime Minister Narendra Modi has assured that the state will soon develop a nose vaccine.
(With input from the agency)
Ludhiana: The police have submitted FIR to four identified and at least 40 unknown attackers…
SonÄ«pat / Ludhiana / Ambala: Actor Punjabi - Activist Activist Deep Sidhu, who died in…
PATIALA / MANSA / BARNALA: Attacking Prime Minister Narendra Modi and AAP National Convener Kejriawal,…
Jalandhar: BJP and AAM AAM AADMI parties are one party, Secretary General of the Ajay…
Ludhiana: Minister of Union Culture Meenakshi Lekhi while campaigning to support the BJP candidate from…
Machhiwara (Ludhiana): AAM AAM AADMI Party (AAP) Head of Punjab Candidate and Members of Parliament…